Zytoprotec is developing drugs using a novel therapeutic approach cytoprotection. Lead product, PD-protec. Is being developed to improve the survival of patients on peritoneal dialysis. A treatment for kidney failure. Has shown safety and promising efficacy effects in a Phase I/II trial. A randomized, blinded, multicenter Phase II trial has commenced at the end of Q2 2014.
http://www.zytoprotec.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
1.3 seconds
Zytoprotec GmbH
Michael Hoffmann
Mariann●●●●●●●28/EG/2
W●n , 1090
AUSTRIA
View this contact
Zytoprotec GmbH
Michael Hoffmann
Mariann●●●●●●●28/EG/2
W●n , 1090
AUSTRIA
View this contact
A1 Telekom Austria AG
Domain Admin
Fading●●●●●●asse 6
L●z , AT, 4020
AUSTRIA
View this contact
BUY YOUR DOMAIN
17
YEARS
3
MONTHS
14
DAYS
ASCIO TECHNOLOGIES, INC.
WHOIS : whois.ascio.com
REFERRED : http://www.ascio.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
1
SITE IP
62.116.5.254
LOAD TIME
1.325 sec
SCORE
6.2
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung | zytoprotec.com Reviews
https://zytoprotec.com
Zytoprotec is developing drugs using a novel therapeutic approach cytoprotection. Lead product, PD-protec. Is being developed to improve the survival of patients on peritoneal dialysis. A treatment for kidney failure. Has shown safety and promising efficacy effects in a Phase I/II trial. A randomized, blinded, multicenter Phase II trial has commenced at the end of Q2 2014.
zytoprotec.com
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung
http://www.zytoprotec.com/therapeutic.php
Cytoprotection—A Novel Therapeutic Approach. During evolution, cells of all species have developed and optimized a powerful mechanism to protect against stress. Every clinically relevant insult therefore not only causes cellular injury but also activates the cellular stress response. However, this mechanism is inhibited in certain diseases or when substances are applied that are “new” from an evolution biology perspective such as PD solutions. Research conducted by Zytoprotec.
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung
http://www.zytoprotec.com/overview.php?cat=zyto
Is a clinical stage life sciences company based in Vienna, Austria. The Company s lead product, PD-protec. Is a patent-protected solution for peritoneal dialysis. PD-protec. Has moved into a randomized, blinded, multicenter Phase II trial at the end of Q2 2014. S pipeline is ICO-protec. A cytoprotective PD solution to address the market for non-glucose based PD solutions. ICO-protec. Is in preclinical development.
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung
http://www.zytoprotec.com/index.php
Zytoprotec is developing drugs using a novel therapeutic approach cytoprotection. Lead product, PD-protec. Is being developed to improve the survival of patients on peritoneal dialysis. A treatment for kidney failure. Has shown safety and promising efficacy effects in a Phase I/II trial. A randomized, blinded, multicenter Phase II trial has commenced at the end of Q2 2014.
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung
http://www.zytoprotec.com/kontakt.php
Mariannengasse 28/2 1090 Wien. 43 1 406 20 02. 43 1 406 20 02 -20. IBAN: AT84 1200 0100 0182 9778. Firmenbuchnummer: FN 294995t Wien. 3 Mit Ausnahme der vorherigen beschränkten Genehmigung wird Ihnen weder eine Lizenz noch irgendein Anspruch auf die Information oder ein Urheberrecht der Zytoprotec GmbH oder irgendeines anderen erteilt oder übertragen. 4 Die Websites der Zytoprotec GmbH können Marken, Patente, geschützte Informationen, Technologien, Produkte, Prozesse oder andere Markenschutzrechte der Zy...
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung
http://www.zytoprotec.com/patents.php
In 2008, Zytoprotec. Filed for an international patent for the use of alanyl-glutamine dipeptide, the active cytoprotective compound in PD-protec. The patent specification was published early in 2012 and the patent was granted for Europe on 23 October 2012. In addition, patent protection exists in Canada, Hong Kong and Japan, while in the U.S.A. the granting process is not yet entirely finished. EU and PCT applications have been made. We went into the national phases in 2014.
TOTAL PAGES IN THIS WEBSITE
7
www.mlm-labs.com: Clients
http://www.mlm-labs.com/Clients.346.0.html
We are proud to list a selection of our clients as references for the service provided by MLM:. ABF Pharmaceutical Services GmbH, Vienna, Austria, www.abf-pharma.com. AB2BIO, Lausanne, Switzerland, www.ab2bio.com. AC Immune SA, Lausanne, Switzerland, www.acimmune.com. Argint International, Budapest, Hungary, www.argintinternational.com. Bayer Pharma AG, Wuppertal, Germany www.bayer.com. Bionorica SA, Neumarkt, Germany, www.bionorica.de. BioNTech AG, Mainz, Germany www.biontech.de.
TOTAL LINKS TO THIS WEBSITE
1
青岛致远通信技术有限公司Powered by ESPCMS
Http:/ www.zytop.net/upfile/2015/08/11/20150811082244 288.jpg. Http:/ www.zytop.net. Http:/ www.zytop.net/upfile/2015/08/13/20150813153618 624.jpg. Http:/ www.zytop.net. Http:/ www.zytop.net/upfile/2015/08/11/20150811082113 254.jpg. Http:/ www.zytop.net. Http:/ www.zytop.net/upfile/2015/08/11/20150811095456 791.jpg. Http:/ www.zytop.net. 版权所有 @ 青岛致远远景通信技术有限公司，Inc,保留所有权利 鲁ICP备06316542号. 电话 0532-81112098 邮编 266071 电子邮件 faxlm@126.com 青岛市山东路33号新园公寓1号楼501室.
zytopia.com - This website is for sale! - Zytopia Zytopia Resources and Information.
Praxisgemeinschaft Zytodiagnostik Neubrandenburg, gynäkologische Zytodiagnostik
Dipl-Biologin S. Stölting und Dipl.-Biologin Birgit Pöschel,. D-17094 Cölpin OT Neu Käbelich, Mecklenburg-Vorpommern. Tel: (03966) 211 641 Fax.: (03966) 211 643 E-Mail: info (at) zytopraxis.de. Herzlich willkommen auf den Seiten der Praxisgemeinschaft Zytodiagnostik GbR. 03092011 Regionaltagung VDCA in Quedlinburg, Workshop. 10092011 Regionaltagung VDCA in Kiel, Workshop. Wir möchten Ihnen einen Einblick in die Arbeit unseres Labors und Informationen. Der Bereich der extragenitalen Zytodiagnostik. Unser ...
ZYTO Professional Product Line
ZYTO Professional Product Line
Zytoprotec GMBH, Einrichtung zur medizinischen und biomedizinischen Forschung
Zytoprotec is developing drugs using a novel therapeutic approach cytoprotection. Lead product, PD-protec. Is being developed to improve the survival of patients on peritoneal dialysis. A treatment for kidney failure. Has shown safety and promising efficacy effects in a Phase I/II trial. A randomized, blinded, multicenter Phase II trial has commenced at the end of Q2 2014.
Zytor Communications Home Page
This page is under reconstruction. The SYSLINUX home page. The Anvin family home page.
女王的皇冠,瑞博国际开户_遵义通源丰田汽车销售服务有限公司
KimL 150420图图 150411/12 澳门机场 明洙 7P. KimL 150422图图 150422 明洙INS更新 1P. XFF61;❀ *ﾟ‘ﾟ･✿.｡.:*.:｡❀ *ﾟ‘ﾟ･✿.｡.:*.:ÿ. KimL 150423图图 150423 INFINITE 官推更新 明洙2P. KimL 150423图图 150423dr.o s.clinic INS更新与明洙合照 1P. CR:dro s.clinic 旧图. KimL 150421图图 150421 日杂 韩流ぴあ 明洙相关 5P. CR: infinite chi、ぴあチャンネル 转自L In Passion 金明洙中文个站. KimL 130920图文 金明洙 你该被抱紧 有风我来顶. 他是出名的颜赞却低调的不像话 L君高贵冷艳 金明洙又呆又萌还有点儿傻 我很喜欢他 喜欢他安安静静不爱说话默默努力的样子 喜欢那个害羞的说大家好我是. KimL 150424图图 日杂 CanCam 6月号扫图 明洙相关 10P. KimL 150415外交 林心如吧邀您共同关注4.19 我们相爱吧. KimL 150421图图 150...
www.zytoscanner.com
Home Page
Knowledge is a Powerful Medicine! WHAT IS MY BIOLOGICAL PREFERENCE? Take the next step forward in your care as you consider information specifically about your body. At ZYTO we recognize and respect the uniqueness of each individual and understand that there is more than meets the eye when. It comes to your body, and your health. That's why our technology. Tools and applications focus on this fundamental reality – each. Of us is unique! The truly gifted healers of our day. If you include orange and brocc...
Zytoservice Berlin | Welcome
Commiment to our customers. Welcome to Zytoservice Berlin. Zytoservice Berlin is a pharmaceuticals manufacturer with authorisation to manufacture medicinal products according to 13 of Germany's medicines act (Arzneimittelgesetz). We produce medicinal infusions tailor-made to the needs of individual patients, as well as other parenteral medication, in state-of-the-art, clean room laboratories.
